Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jatinder Lamba

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Pharmacogenomics|October 13, 2012
Assessment of healthcare students' views on pharmacogenomics at the University of MinnesotaMeg Moen, Jatinder Lamba
Current Drug Metabolism|August 17, 2005
Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogeneticsJatinder Lamba, Vishal Lamba, Erin Schuetz
Journal of Pediatric Hematology/Oncology|July 1, 2020
Potential Risk Factors Associated With Graft Failure of Haploidentical Hematopoietic Stem Cell Transplantation in Children With Sickle Cell DiseaseJasmin Yu, Vandy Black, Jatinder Lamba, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 11, 2007
Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expressionJatinder Lamba, Vishal Lamba, Stephen Strom, et al.
Scientific Reports|April 5, 2018
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid LeukemiaBradley Stockard, Timothy Garrett, Joy Guingab-Cagmat, et al.
BMC Bioinformatics|October 22, 2016
CC-PROMISE effectively integrates two forms of molecular data with multiple biologically related endpointsXueyuan Cao, Kristine R Crews, James Downing, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2006
Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot studyPeter L Anderson, Jatinder Lamba, Christina L Aquilante, et al.
Pharmacogenetics and Genomics|March 13, 2012
PharmGKB summary: very important pharmacogene information for CYP3A5Jatinder Lamba, Joan M Hebert, Erin G Schuetz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 9, 2008
Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphismsBalasubramanian Poonkuzhali, Jatinder Lamba, Stephen Strom, et al.
Pharmacogenetics and Genomics|September 11, 2012
PharmGKB summary: zidovudine pathwayYogita Ghodke, Peter L Anderson, Katrin Sangkuhl, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Pharmacogenomics|October 13, 2012
Assessment of healthcare students' views on pharmacogenomics at the University of MinnesotaMeg Moen, Jatinder Lamba
Current Drug Metabolism|August 17, 2005
Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogeneticsJatinder Lamba, Vishal Lamba, Erin Schuetz
Journal of Pediatric Hematology/Oncology|July 1, 2020
Potential Risk Factors Associated With Graft Failure of Haploidentical Hematopoietic Stem Cell Transplantation in Children With Sickle Cell DiseaseJasmin Yu, Vandy Black, Jatinder Lamba, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 11, 2007
Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expressionJatinder Lamba, Vishal Lamba, Stephen Strom, et al.
Scientific Reports|April 5, 2018
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid LeukemiaBradley Stockard, Timothy Garrett, Joy Guingab-Cagmat, et al.
BMC Bioinformatics|October 22, 2016
CC-PROMISE effectively integrates two forms of molecular data with multiple biologically related endpointsXueyuan Cao, Kristine R Crews, James Downing, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2006
Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot studyPeter L Anderson, Jatinder Lamba, Christina L Aquilante, et al.
Pharmacogenetics and Genomics|March 13, 2012
PharmGKB summary: very important pharmacogene information for CYP3A5Jatinder Lamba, Joan M Hebert, Erin G Schuetz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 9, 2008
Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphismsBalasubramanian Poonkuzhali, Jatinder Lamba, Stephen Strom, et al.
Pharmacogenetics and Genomics|September 11, 2012
PharmGKB summary: zidovudine pathwayYogita Ghodke, Peter L Anderson, Katrin Sangkuhl, et al.
Pageof 4